Earnings Feed
Start Free
$PVCT·4

PROVECTUS BIOPHARMACEUTICALS, INC. · Mar 24, 5:17 PM ET

PROVECTUS BIOPHARMACEUTICALS, INC. 4

4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Mar 24, 2014

Insider Transaction Report

Form 4
Period: 2014-03-20
PROVECTUS BIOPHARMACEUTICALS, INC.PVCT
WACHTER ERIC PHD
DirectorVice President Pharmaceuticals
Transactions
  • Exercise/Conversion

    Common Stock

    2014-03-20$0.93/sh+600,000$558,000→ 6,032,484 total
  • Exercise/Conversion

    Employee Stock Option (Right to buy)

    2014-03-20−600,000→ 0 total
    Exercise: $0.93From: 2011-09-06Exp: 2021-09-06→ Common Stock (600,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-03-20$0.75/sh+14,248$10,686→ 5,432,484 total
  • Exercise/Conversion

    Employee Stock Option (Right to buy)

    2014-03-20−25,000→ 0 total
    Exercise: $0.95From: 2004-05-27Exp: 2014-05-27→ Common Stock (25,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-03-20$0.95/sh+25,000$23,750→ 5,418,236 total
  • Exercise/Conversion

    Employee Stock Option (Right to buy)

    2014-03-20−14,248→ 0 total
    Exercise: $0.75From: 2005-05-25Exp: 2015-05-25→ Common Stock (14,248 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    4,867

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4